SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination
16 references·4 citing·45 second hop
Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination (2018)Psilocybin modulates functional connectiv…Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms (2017)Psilocybin for treatment-resi…Neural correlates of the LSD experience revealed by multimodal neuroimaging (2016)Neural correlates of the LSD …LSD‐induced entropic brain activity predicts subsequent personality change (2016)LSD‐induced entropic brain ac…Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers (2014)Psilocybin-Induced Decrease i…Psilocybin – Summary of knowledge and new perspectives (2013)Psilocybin – Summary of knowl…Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors (2012)Psilocybin Biases Facial Reco…Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Neural correlates of the psyc…The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)The neurobiology of psychedel…How the Neurocircuitry and Genetics of Fear Inhibition May Inform Our Understanding of PTSD (2010)How the Neurocircuitry and Ge…Use of fMRI to Predict Recovery From Unipolar Depression With Cognitive Behavior Therapy (2006)Use of fMRI to Predict Recove…Dose-Dependent Decrease of Activation in Bilateral Amygdala and Insula by Lorazepam During Emotion Processing (2005)Dose-Dependent Decrease of Ac…The Positive and Negative Affect Schedule (PANAS): Construct validity, measurement properties and normative data in a large non‐clinical sample (2004)The Positive and Negative Aff…5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride (1999)5-HT Modulation of Dopamine R…The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans (1998)The Standardized Psychometric…Untersuchungen mit einer deutschen Version der "Positive and Negative Affect Schedule" (PANAS). (1996)Untersuchungen mit einer deut…Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence (1995)Multiple choice vocabulary te…The Psychedelic Future of Post-Traumatic Stress Disorder Treatment (2024)The Psychedelic Future of Pos…Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults (2021)Low doses of LSD reduce broad…Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders (2021)Classical Psychedelics as The…Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019)Modulation of Social Cognitio…Handbuch der Psychologie (2006)How similar are fluid cognition and general intelligence? A developmental neuroscience perspective on fluid cognition as an aspect of human cognitive ability (2006)Oxytocin enhances brain reward system responses in men viewing the face of their female partner (2013)Examining the effects of birth order on personality (2015)Hallucinogens (2004)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction (2014)Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (2015)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)"A Controlled Study" (1966)Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function (2018)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)Psychedelics and Psychedelic-Assisted Psychotherapy (2020)The Hospital Anxiety and Depression Scale (1983)Development and validation of brief measures of positive and negative affect: The PANAS scales. (1988)Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives (1999)Does positive affect influence health? (2005)The short‐form version of the Depression Anxiety Stress Scales (DASS‐21): Construct validity and normative data in a large non‐clinical sample (2005)Development and Validation of an Internationally Reliable Short-Form of the Positive and Negative Affect Schedule (PANAS) (2007)Emotional processing of fear: Exposure to corrective information. (1986)Posttraumatic Stress Disorder in the National Comorbidity Survey (1995)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Amygdala Volume Changes in Posttraumatic Stress Disorder in a Large Case-Controlled Veterans Group (2012)Current status on behavioral and biological markers of PTSD: A search for clarity in a conflicting literature (2013)Prefrontal cortex, amygdala, and threat processing: implications for PTSD (2021)Response styles and the duration of episodes of depressed mood. (1993)Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study (2001)Neurobehavioral Therapies in the 21st Century: Summary of an Emerging Field and an Extended Example of Cognitive Control Training for Depression (2007)Neural correlates of rumination in depression (2010)The Anatomy of Anger: An Integrative Cognitive Model of Trait Anger and Reactive Aggression (2010)Cognitive Therapy for Depression (2012)The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (2014)The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (2017)Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression (2018)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)The entropic brain - revisited (2018)Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study (2004)Serotonin research: contributions to understanding psychoses (2008)Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory (2019)Emotion-regulation skills as a treatment target in psychotherapy (2008)Emotion regulation and vulnerability to depression: Spontaneous versus instructed use of emotion suppression and reappraisal. (2010)Measuring Teachers’ enjoyment, anger, and anxiety: The Teacher Emotions Scales (TES) (2016)
this work references cited by second hop

References

  • 2004The Positive and Negative Affect Schedule (PANAS): Construct validity, measurement properties and normative data in a large non‐clinical sample2,954 cited
  • 2012Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin1,170 cited
  • 2016Neural correlates of the LSD experience revealed by multimodal neuroimaging857 cited
  • 2010The neurobiology of psychedelic drugs: implications for the treatment of mood disorders720 cited
  • 1995Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence617 cited
  • 1996Untersuchungen mit einer deutschen Version der "Positive and Negative Affect Schedule" (PANAS).609 cited
  • 2017Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms587 cited
  • 1998The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans577 cited
  • 2006Use of fMRI to Predict Recovery From Unipolar Depression With Cognitive Behavior Therapy495 cited
  • 2010How the Neurocircuitry and Genetics of Fear Inhibition May Inform Our Understanding of PTSD440 cited
  • 2014Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers323 cited
  • 2016LSD‐induced entropic brain activity predicts subsequent personality change317 cited
  • 2005Dose-Dependent Decrease of Activation in Bilateral Amygdala and Insula by Lorazepam During Emotion Processing

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

314 cited
  • 19995-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride304 cited
  • 2012Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors298 cited
  • 2013Psilocybin – Summary of knowledge and new perspectives275 cited
  • Cited by

    • 2024The Psychedelic Future of Post-Traumatic Stress Disorder Treatment80 cited
    • 2021Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults74 cited
    • 2019Modulation of Social Cognition via Hallucinogens and “Entactogens”71 cited
    • 2021Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders65 cited